Eve & Co Receives Licence Amendment to Sell Cannabis Extracts, Edibles and Topicals
July 20 2020 - 9:24AM
Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-C:
EVE; QTCQX: EEVVF) is pleased to announce that Health Canada
approved on July 17, 2020 an amendment to the licence of its
wholly-owned subsidiary Natural MedCo Ltd.(“NMC”) granting the sale
of cannabis extracts, edibles and topicals.
This licensing amendment will allow the Company
to significantly expand its product offering to consumer markets.
It has submitted four additional products’ (Cannabis 2.0) Stock
Keeping Units (“SKUs”) to Health Canada. These products are
expected to be released in the third and fourth quarters of 2020.
The Company plans on submitting more SKUs in the coming months as
it expands its product line within female-focused categories. The
Company has entered into letters of intent with Colio Estate Wines
and Dr Kerklaan Therapeutics as previously announced on November
22, 2019 and January 30, 2020 respectively, for the development of
cannabis-infused beverage and topical products, respectively and
this licensing amendment permits the sale of such products as and
when they are developed and released to consumer markets.
“We are thrilled to expand our product offerings
into the recreational market to better provide alternative methods
of consumption beyond flower. This is a significant step in our
journey and our Product Development team has worked tirelessly on
building partnerships with well-established and successful
manufacturers. We are excited to move forward in bringing
innovative products to the market, which we believe women need from
their cannabis edibles, extracts and topicals. As one of the
largest cannabis facilities with EU-GMP certification, we are
looking forward to the future of the supply of additional products
into the European Union and continuing to work with our partners,
one of whom (Bavaria Weed GMbH) also recently received its EU-GMP
certification,” said Melinda Rombouts, President and CEO of Eve
& Co.
The Company is also pleased to announce that it
has received Health Canada’s approval on July 6, 2020 for the
renewal of its licence for standard cultivation, standard
processing and sale for recreational purposes under the Cannabis
Regulations. The licence has been renewed for a further three
years, effective until July 6, 2023.
About Eve & Co
Incorporated
Eve & Co, through its wholly-owned
subsidiary NMC, holds cultivation and processing licences under the
Cannabis Act (Canada) for the production and sale of various
cannabis products, including dried cannabis, cannabis plants and
extraction of cannabis oil and has received its European Union
certificate of Good Manufacturing Practice which allows Eve to
distribute its products to the EU. NMC was Canada’s first
female-founded licensed producer of medicinal marijuana and
received its cultivation licence from Health Canada in 2016. Eve
& Co is led by a team of agricultural experts and has a
licensed 1,000,000 square foot greenhouse located in Strathroy,
Ontario.
The Company’s website can be visited at
www.evecannabis.ca.
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Notice regarding forward-looking
statements:
Certain statements in this press release
constitute forward-looking information. All statements other than
statements of historical fact contained in this press release,
including, without limitation, those regarding the approval of new
products, the successful production and launch of the Company’s new
cannabis derivative products, consumer preferences, competition,
opportunities for growth, future, strategy, plans, objectives,
goals and targets, and any statements preceded by, followed by or
that include the words “believe”, “expect”, “aim”, “intend”,
“plan”, “continue”, “will”, “may”, “would”, “anticipate”,
“estimate”, “forecast”, “predict”, “project”, “seek”, “should” or
similar expressions or the negative thereof, are forward-looking
statements. These statements are not historical facts but instead
represent only the Company’s expectations, estimates and
projections regarding future events. These statements are not
guarantees of future performance and involve assumptions, risks and
uncertainties that are difficult to predict, including those
described in the Company’s management’s discussion and analysis for
the three months ended March 31, 2020 which is available on the
Company’s SEDAR profile. Therefore, actual results may differ
materially from what is expressed, implied or forecasted in such
forward-looking statements. The forward-looking information and
forward-looking statements included in this news release are made
as of the date of this news release. The Company does not undertake
an obligation to publicly update such forward-looking information
or forward-looking information to reflect new information,
subsequent events or otherwise unless required by applicable
securities law.
For further information, please contact:
Melinda Rombouts President and Chief Executive Officer Eve & Co
Incorporated Telephone: (855)
628-6337
Eve & (TSXV:EVE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eve & (TSXV:EVE)
Historical Stock Chart
From Jul 2023 to Jul 2024